Colorectal cancer

CHICAGO--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from ML18147, a Phase III study in metastatic colorectal cancer (mCRC) that evaluated Avastin® (bevacizumab) continued with second-line chemotherapy in people who received initial Avastin plus first-line chemotherapy. The study met its primary endpoint of a significant increase in overall survival (OS). In the study, the...  

CHICAGO (Reuters) - Colorectal cancer patients treated with a follow-up round of Avastin fare better than those given chemotherapy alone after their disease has worsened, according to results of a large clinical trial. Avastin, sold by Roche, is approved as a first-line or second-line treatment for colorectal cancer, but not for both. Sales of the drug, also known as bevacizumab, totaled $5.3 billion Swiss francs ($5.5 billion) last year. ...  

Flexible sigmoidoscopy and colonoscopy are more effective than fecal occult blood testing in diagnosing polyps that may result in colorectal cancer. The risk of colorectal cancer is reduced by the removal of pre-cancerous polyps by sigmoidoscopy.  

Although some people may feel embarrassed about the idea of colorectal cancer screening and are worried about some of the procedures that are used, colorectal cancer screening decreases the risk of dying from colon cancer. So, it's important to push past ...  

Filed under: News Foreigner Michael Bluestein, the keyboardist for Foreigner, has been forced to take an indefinite leave from the group after being diagnosed with colorectal cancer. While the band made no official statement on its site, via Twitter or Facebook, Bluestein posted on the band's message board Tuesday (May 29) with the news. "I recently went to the hospital following some symptoms, and it was discovered that I have...  

The new report features extensive primary research with Russian oncologists as well as a market outlook by drug and class through 2016 and colorectal cancer epidemiology through 2021. About Emerging Markets Reports Decision Resources is the ...  

Flexible sigmoidoscopy, a screening test for colorectal cancer that is less invasive and has fewer side effects than colonoscopy, is effective in reducing the rates of new cases and deaths from colorectal cancer, according to research sponsored by the National Cancer Institute, part of the National Institutes of Health.  

Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston. SAN DIEGO -- Type 2 diabetes patients may need to be screened earlier for colorectal cancer, researchers said here. In a single-center ...  

Overall, colorectal cancer deaths were reduced 26 percent and new cases were reduced 21 percent as a result of screening with sigmoidoscopy, according to findings of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial that appeared ...  

In particular, if the taste or the sheer volume of bowel prep causes a patient to drink less of it, it could prevent adequate cleansing of the colon, making it harder for the physician to detect polyps. "If the bowel prep experience is intolerable for the ...  

SAN DIEGO – The incidence of colorectal cancer among men and women who underwent flexible sigmoidoscopy, with a repeat screening every 3 or 5 years, was reduced by 21%, compared with those who received usual care, according to the findings of a large ...  

It is one of the few studies to also address the influence of a person’s mistrust of medical providers and misconceptions, such as the notion that CRC screening might cause AIDS. The AIDS issue warrants further investigation, said Jason Q. Purnell ...  

BIRMINGHAM, Alabama -- A national study that involved UAB researchers and about 6,100 Alabama volunteers found that screening for colorectal cancer by a procedure less invasive than colonoscopy can reduce cancer incidence by 21 percent and death ...  

Current colorectal cancer screening guidelines for individuals with first-degree relatives with precancerous colon polyps are based on studies that were not properly designed or were too limited to shape those guidelines, according to a new systemic review of research on the topic. The review authors call for new studies to measure the risk and identify the factors that modify it.  

The search was updated until the end of June 2011. The inclusion criteria were: (i) surveillance colonoscopy of known colorectal adenomas or cancer, or screening colonoscopy in patients with a positive test of fecal blood; (ii) diagnostic colonoscopy in ...